Literature DB >> 10887171

Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-alpha (TNF-alpha ) signal transduction in L929 cells. Translocation and inactivation of PKC by TNF-alpha.

J Y Lee1, Y A Hannun, L M Obeid.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is capable of inducing a variety of biologic responses through multiple signaling pathways. Because of the potential role of protein kinase C (PKC) in apoptosis, we examined the effects and mechanisms of TNF-alpha on PKC regulation, specifically on PKC alpha. In L929 murine fibroblasts, TNF-alpha (0.5- 5 nm) caused potent inhibition of PKC alpha activity and induced translocation of PKC alpha from the cytosol to the membrane. Treatment of cells with TNF-alpha also induced dephosphorylation of PKC alpha as detected by a mobility shift on SDS-polyacrylamide gel and inhibition of PKC phosphorylation as probed by anti-phospho-PKC antibodies. Since PKC is activated directly by diacylglycerol and inactivated indirectly by ceramide, we next examined the roles of these lipid mediators in the regulation of PKC alpha. Addition of TNF-alpha led to accumulation of both ceramide and diacylglycerol. Fumonisin B(1), an inhibitor of ceramide synthase, and glutathione, an inhibitor of neutral sphingomyelinase, both reversed the effect of TNF-alpha on PKC alpha activity, suggesting that ceramide production is necessary for the action of TNF-alpha. The diacylglycerol mimic phorbol 12-myristate 13-acetate was sufficient to cause translocation of PKC alpha, but not the mobility shift. Okadaic acid at 2 nm, a potent protein phosphatase inhibitor, blocked the effects of TNF-alpha on PKC alpha activity, but not on PKC alpha translocation, thus demonstrating that dephosphorylation and translocation are independent processes. These results demonstrate that PKC alpha acts as a downstream target for TNF-alpha and that different lipid-mediated pathways in TNF-alpha signaling lead to opposing signals in the regulation of PKC alpha activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887171     DOI: 10.1074/jbc.M000170200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

3.  Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation.

Authors:  R Liu; N Wei; W Guo; O Qiang; X Li; Y Ou; W Huang; C W Tang
Journal:  Eur J Nutr       Date:  2012-07-18       Impact factor: 5.614

4.  Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.

Authors:  Ahmed A A Mohamed; Orla J Jupp; Helen M Anderson; Alison F Littlejohn; Peter Vandenabeele; David J MacEwan
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Positive feedback of protein kinase C proteolytic activation during apoptosis.

Authors:  Sabrina Leverrier; Alice Vallentin; Dominique Joubert
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

6.  PKCdelta mediates thrombin-augmented fibroblast-mediated collagen gel contraction.

Authors:  Qiuhong Fang; Lijun Mao; Tetsu Kobayashi; Xingqi Wang; Todd A Wyatt; Huijung Kim; Xiangde Liu; Stephen I Rennard
Journal:  Biochem Biophys Res Commun       Date:  2008-03-13       Impact factor: 3.575

7.  Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells.

Authors:  Christopher J Clarke; J Michael Guthrie; Yusuf A Hannun
Journal:  Mol Pharmacol       Date:  2008-07-24       Impact factor: 4.436

Review 8.  Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa.

Authors:  Joshua M Royal; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2017-11-23       Impact factor: 4.546

9.  Protection mechanism of early hyperbaric oxygen therapy in rats with permanent cerebral ischemia.

Authors:  Min Yu; Yixue Xue; Weidi Liang; Yupeng Zhang; Zhiqiang Zhang
Journal:  J Phys Ther Sci       Date:  2015-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.